Home > News > BioSante Reports Product Development Highlights
November 10th, 2005
BioSante Reports Product Development Highlights
Abstract:
"We achieved milestones across our key clinical programs this quarter. We presented positive Phase III data for Bio-E-Gel(TM), licensed three patents that cover the use of testosterone (LibiGel(TM)) to treat hypoactive sexual desire disorder in women on hormone contraception, and entered into an allergy licensing option agreement for our CaP nanotechnology," said Stephen M. Simes, BioSante's president and chief executive officer.
Source:
businesswire 
  
| Related News Press | 
Products
    Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018
    Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018
    Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018
    Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018
Profiles
    Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
    Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
    Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
    Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
Announcements
    Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Financial Reports
    Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
    Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
| 
			 | 
	||
| 
			 | 
	||
| The latest news from around the world, FREE | ||
| 
			 | 
	||
| 
			 | 
	||
| Premium Products | ||
| 
			 | 
	||
| 
			Only the news you want to read! 
			 Learn More  | 
		||
| 
			 | 
	||
| 
			Full-service, expert consulting 
			 Learn More  | 
		||
| 
			 | 
	||